EVIO Labs Florida Awarded for Accuracy in Testing
EVIO Labs Florida (Broward County, Florida) was recently recognized for their participation in The Emerald Test (Emerald Scientific), which is an interlaboratory comparison and proficiency assessment for cannabis testing. According to the company’s press release, EVIO Florida was recognized by Emerald for their accuracy in potency in solution, residual solvents, terpenes, microbial 2, aspergillus mold, pesticide screening, and mycotoxin testing.
“Our experienced team of chemists are among the best in the industry and these awards provide the acknowledgement of our efforts to operate above the standard,” said Chris Martinez, President EVIO Florida, in the press release.
The Emerald Test reportedly uses the standard interlaboratory comparison proficiency testing (ILC/PT) program for evaluating how accurately and dependably testing laboratories perform, by comparing how well the laboratory measures blinded samples. ILC/PT programs are common in many testing industries (such as environmental, food, pharmaceutical, and more), and provide a point of reference on how well testing laboratories perform individually and collectively.
According to the company, the Emerald Test acknowledgement helps demonstrate EVIO Florida’s aptitude and competence in conducting analytical testing at a higher standard of excellence for Florida’s cannabis industry. In addition, the Emerald Test badge results provide a measure of assurance and reliability to those who depend on precise laboratory results for patient safety, public health, and product precision.
For more information, contact info@eviolabsfl.com.
Ep 25: Cannabis Quality Differentiation Beyond Cannabinoid Content
February 28th 2025In this latest installment of Noid Knowledge we are joined by Julie Kowalski, a leading mind in analytical chemistry and cannabis testing. Julie has arranged a very compelling symposium for Pittcon entitled Cannabis Aroma: Advances and Challenges in Determining and Commercializing Cannabis Product Quality Attributes. It is taking place on Wednesday, March 5, 2025, starting at 9:30 AM in room 209. The session features top notch speakers, including several previous guests of this show, and yours truly, discussing the next generation of quality assessment in cannabis.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
The Cost of Compliance in the Cannabis Industry
April 1st 2025The financial and reputational risks of non-compliance far outweigh the upfront investment required to establish robust compliance systems. This blog explores the true cost of compliance, what non-compliance can mean for a business, and why investing in compliance is a proactive, strategic decision rather than a burdensome expense.
